Nova Primary Glucose Analyzer System
Glucose Oxidase, Glucose. 510(k) K203549, from Nova Biomedical Corporation (Waltham, ME). Product code CGA, class 2.
As of Nov 17, 2026, K203549 is an FDA 510(k) held by Nova Biomedical Corporation, substantially equivalent on Oct 18, 2022 after 683 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Oct 18, 2022
- Review time: 683 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Nova Primary Glucose Analyzer System is indicated for in vitro diagnostic use by healthcare professionals in clinical laboratory setting for the quantitative determination of Glucose in lithium heparinized venous whole blood and plasma.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Ysi Model 2300 Stat Glucose And L-Lactate AnalyzerK891480 · Yellow Springs Instrument Co., Inc. · May 22, 1989
Other CGA Clearances
The newest 510(k)s for the same product code; their median review was 266 days; see every CGA device- ABL90 FLEX PLUS SystemK252488 · Radiometer Medicals Aps · May 1, 2026
- YSI 2900C Biochemistry AnalyzerK210933 · Ysi, Inc. · Sep 30, 2024
- EasyStat 300K220328 · Medica Corporation · Jul 26, 2024
- i-STAT G cartridge with the i-STAT 1 SystemK223755 · Abbott Point of Care, Inc. · Sep 11, 2023
- i-STAT CG8+ cartridge with the i-STAT 1 SystemK223710 · Abbott Point of Care, Inc. · Jul 28, 2023
- GEM Premier ChemSTATK223090 · Instrumentation Laboratory CO · Jan 27, 2023
- i-STAT CHEM8+ cartridge with the i-STAT 1 SystemK210958 · Abbott Point of Care, Inc. · Aug 13, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 4, 2020
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files